Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis of Tdap-IPV whole blood immune responses II

ABSTRACT: Transcriptomic analysis of Tdap-IPV whole blood immune responses II

PROVIDER: PRJNA978103 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24785411_1.fastq.gz	Fastqsanger.gz
	SRR24785411_2.fastq.gz	Fastqsanger.gz
	SRR24785412_1.fastq.gz	Fastqsanger.gz
	SRR24785412_2.fastq.gz	Fastqsanger.gz
	SRR24785413_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Transcriptomic analysis of Tdap-IPV whole blood immune responses II

Project description:Control of pertussis depends on primary vaccination of infants in combination with booster vaccination of children, adults, and recently also pregnant women. Tetanus-diptheria-acellular pertussis (Tdap) booster vaccines are frequently given in many countries and can be formulated with inactivated poliovirus (Tdap-IPV). Although Tdap-IPV provides clinical protection, both pertussis antibody levels and clinical protection decay shortly after vaccination. This highlights the need for a better understanding of the mechanisms of immunogenicity of aP-containing combination vaccines, which may explain the longevity of the antibody response to vaccination. In order to identify immune signatures that are induced by Tdap-IPV vaccination and which can be associated with humoral responses, we analyzed changes in gene expression.

2024-01-22 | GSE233855 | GEO

Transcriptomic analysis of Tdap-IPV whole blood immune responses

2024-01-22 | GSE195625 | GEO

Transcriptomic analysis whole blood single innate immune cells for analysis of of Tdap-IPV immune responses

Project description:Control of pertussis depends on primary vaccination of infants in combination with booster vaccination of children, adults, and recently also pregnant women. Tetanus-diptheria-acellular pertussis (Tdap) booster vaccines are frequently given in many countries and can be formulated with inactivated poliovirus (Tdap-IPV). Although Tdap-IPV provides clinical protection, pertussis antibody levels decay shortly after vaccination. This highlights the need for a better understanding of the mechanisms of immunogenicity of aP-containing combination vaccines, which may explain the longevity of the antibody response to vaccination. In order to identify immune signatures that are induced by Tdap-IPV vaccination and which may be associated with humoral responses, we analyzed changes in gene expression.

2024-01-22 | GSE195626 | GEO

Transcriptomic analysis of Tdap-IPV whole blood immune responses

Project description:Transcriptomic analysis of Tdap-IPV whole blood immune responses

| PRJNA801600 | ENA

Transcriptomic analysis whole blood single innate immune cells for analysis of of Tdap-IPV immune responses

Project description:Transcriptomic analysis whole blood single innate immune cells for analysis of of Tdap-IPV immune responses

| PRJNA801598 | ENA

Early antiviral responses in monocytes and dendritic cells are associated with persistent humoral immunity to pertussis following Tdap-IPV vaccination

Project description:Early antiviral responses in monocytes and dendritic cells are associated with persistent humoral immunity to pertussis following Tdap-IPV vaccination

| PRJNA801507 | ENA

Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens

Project description:High correlation was observed between T cell responses to SARS-CoV-2 and MMR and Tdap vaccine proteins in infected and uninfected individuals; the overlapping T cell population contained an effector memory T cell subset previously implicated in protective anti-viral immunity and their activation required APC-derived IL-15, known to sensitize T cells to activation. We were able to detect cross-reactive TCR repertoire in antigen experienced T cells recognizing SARS-CoV-2, MMR and Tdap epitopes using clonotyping and scRNA-seq. Indices of disease severity were reduced in MMR or Tdap vaccinated individuals by 32-38% and 20-23% respectively, among 73.582 COVID-19 positive patients.

2021-08-02 | GSE181046 | GEO

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.

Project description:Many countries continue to experience pertussis epidemics despite widespread vaccination. Waning protection after booster vaccination has highlighted the need for a better understanding of the immunological factors that promote durable protection. Here we apply systems vaccinology to investigate antibody responses in adolescents in the Netherlands (N = 14; NL) and the United Kingdom (N = 12; UK) receiving a tetanus-diphtheria-acellular pertussis-inactivated poliovirus (Tdap-IPV) vaccine. We report that early antiviral and interferon gene expression signatures in blood correlate to persistence of pertussis-specific antibody responses. Single-cell analyses of the innate response identified monocytes and myeloid dendritic cells (MoDC) as principal responders that upregulate antiviral gene expression and type-I interferon cytokine production. With public data, we show that Tdap vaccination stimulates significantly lower antiviral/type-I interferon responses than Tdap-IPV, suggesting that IPV may promote antiviral gene expression. Subsequent in vitro stimulation experiments demonstrate TLR-dependent, IPV-specific activation of the pro-inflammatory p38 MAP kinase pathway in MoDCs. Together, our data provide insights into the molecular host response to pertussis booster vaccination and demonstrate that IPV enhances innate immune activity associated with persistent, pertussis-specific antibody responses.

| S-EPMC10923912 | biostudies-literature

Transcriptional responses in whole blood of febrile individuals in Nepal

Project description:Transcriptional responses in whole blood of febrile individuals in Nepal

| PRJNA454302 | ENA

Mesomycoplasma hyorhinis strain:MDBK-IPV

Project description:Mesomycoplasma hyorhinis strain:MDBK-IPV Genome sequencing and assembly

| PRJNA335953 | ENA